Medison, has launched a premium ultrasound imaging system ‘RS80A with Prestige’
with an enhanced diagnostic package designed for use in radiology departments
in general hospital and resarch applications.
The new system provides enhanced research power to the existing RS80A
system for use in a broad spectrum of diseases in the fields of abdominal,
breast, cardiovascular, and musculoskeletal disorders.
RS80A with Prestige is equipped with S-Fusion facility, which is a function
that can compare the body parts intended for diagnosis through ultrasound
imaging with CT or MRI imaging simultaneously for analysis. Users can determine
more precisely with the high resolution of CT and MRI imaging, the location of
lesions including those that existing ultrasound imaging alone couldn’t locate.
Auto-registration in the S-Fusion aligns CT or MRI images within 30 seconds to
enable quick diagnoses. The RS80A with Prestige also includes the S-Shearwave
elastography function, which provides quantitative measurements of stiffness using a shear wave
produced around the region of interest, so helping to analyze the
characteristics of body tissue without need for biopsy. The function supports
accurate diagnosis by providing Reliable Measurement Index (RMI) and statistics for repeated measurements.
new system also includes Samsung’s new advanced 3D technology, Natural Vue, a
feature which enhances morphological representation of internal body images
even more than the existing Realistic Vue system which provides realistic
presentation of images. With the application of the 3D/4D reflection mode,
Natural Vue can show even a minute protrusion that basic imaging is unable to
display. The system also includes the Arterial Analysis feature, which supports
earlier detection of cardiovascular diseases by carrying both morphological and
functional analyses of the vessel.
the highly favorable market response to the first RS80A system introduced last
year, it is exciting to now release the RS80A with Prestige featuring
additional research functions and enhanced user capabilities,” said Soo-in Cho,
CEO of Samsung Medison, adding, “Samsung will continue to put its best efforts
in developing ultrasound technology and clinical usability for optimal
diagnosis in the medical field”.